
MTEX
Mannatech Inc
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
9.260
Open
9.255
VWAP
9.01
Vol
8.76K
Mkt Cap
17.11M
Low
8.930
Amount
78.89K
EV/EBITDA(TTM)
19.84
Total Shares
1.88M
EV
15.42M
EV/OCF(TTM)
--
P/S(TTM)
0.15
Mannatech, Incorporated is a global health and wellness solution provider. The Company develops and sells nutritional supplements, skin care and anti-aging products, and weight-management products that target optimal health and wellness. The Company's product category includes Integrative Health, Targeted Health, Weight and Fitness, Skin Care, and Essentials. Integrative Health includes Ambrotose Complex, Ambrotose AO, Advanced Ambrotose, Ambrotose Life, Catalyst, Cognitate, Manapol Powder, MannaBears, and others. Targeted Health includes BounceBack, CardioBALANCE, GI-ProBalance Slimstick, GI-Zyme, GI-Defense, Blood Sugar ProBalance, ImmunoSTART, and others. Weight and Fitness includes OsoLean, SPORT, TruHealth Fat Loss System and others. Skin Care includes Emprizone, FIRM with Ambrotose, FreshDen, and others. Essentials include Catalyst Multivitamin, Liver Support, Joint Support SUPERFOOD, Sleep Support gummies and Stress Support gummies.
Show More
Valuation Metrics
The current forward P/E ratio for Mannatech Inc (MTEX.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Mannatech Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A
5Y Average PS
0.07
Current PS
9.06
Overvalued PS
0.84
Undervalued PS
-0.71
Financials
Annual
Quarterly
FY2025Q2
YoY :
-7.43%
25.68M
Total Revenue
FY2025Q2
YoY :
+26.25%
-1.44M
Operating Profit
FY2025Q2
YoY :
+591.03%
-4.31M
Net Income after Tax
FY2025Q2
YoY :
+587.88%
-2.27
EPS - Diluted
FY2025Q2
YoY :
+40.47%
-3.86M
Free Cash Flow
FY2025Q2
YoY :
-4.49%
73.60
Gross Profit Margin - %
FY2025Q2
YoY :
+646.22%
-16.79
Net Margin - %
FY2025Q2
N/A
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
MTEX News & Events
Events Timeline
2024-11-26 (ET)
2024-11-26
15:30:47
Mannatech names Robert Toth vice chairman of the board
Sign Up For More Events
Sign Up For More Events
News
9.5
09-04BenzingaAmerican Eagle Shares Surge Nearly 23%; Check Out 20 Stocks Making Moves in Premarket Trading
9.5
08-13NASDAQ.COMMannatech Inc. Q2 Loss Increases
9.5
08-12Yahoo FinanceMannatech Reports Financial Results for Second Quarter 2025
Sign Up For More News
People Also Watch

MGIH
Millennium Group International Holdings Ltd
1.590
USD
-1.24%

ATER
Aterian Inc
0.838
USD
-1.06%

YJ
Yunji Inc
1.740
USD
+1.75%

AMS
American Shared Hospital Services
2.110
USD
-0.47%

GELS
Gelteq Ltd
1.070
USD
0.00%

CCM
Concord Medical Services Holdings Ltd
5.570
USD
-1.94%

ATHA
Athira Pharma Inc
4.010
USD
-4.30%

OMEX
Odyssey Marine Exploration Inc
1.920
USD
-2.04%
FAQ
What is Mannatech Inc (MTEX) stock price today?
The current price of MTEX is 9 USD — it has decreased -0.66 % in the last trading day.





